<!--
title: Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent
description: doi: 10.1016/j.jpeds.2021.06.035
published: true
date: 2022-02-11T10:28:19.457Z
tags: vaccine, side, effects, effect, risk, mrna, adverse, covid19, adolescents, study, covid, acute, heart, myocarditis, case
editor: ckeditor
dateCreated: 2022-02-11T10:28:19.457Z
-->

<p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/#">J Pediatr.</a> 2021 Nov; 238: 321–323.</p>
<p>Published online 2021 Jun 22. doi:&nbsp;<a href="https://dx.doi.org/10.1016%2Fj.jpeds.2021.06.035">10.1016/j.jpeds.2021.06.035</a></p>
<p style="text-align:right;">PMCID: PMC8216855</p>
<p style="text-align:right;">PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/34166671">34166671</a></p>
<p>&nbsp;</p>
<h1>Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent</h1>
<p><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Minocha%20PK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34166671">Prashant K. Minocha</a>, MD,<sup>1,∗</sup> <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Better%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34166671">Donna Better</a>, MD,<sup>2</sup> <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Singh%20RK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34166671">Rakesh K. Singh</a>, MD, MS,<sup>1</sup> and <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Hoque%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=34166671">Tasneem Hoque</a>, MD<sup>2</sup></p>
<p>&nbsp;</p>
<p><sup>'</sup>Our patient had his first episode of idiopathic acute myocarditis 4&nbsp;months before recurrence. This recurrent episode of myocarditis may have been triggered by the vaccine administration through an autoinflammatory or autoimmune phenomenon. Cardiac MRI during both illnesses demonstrated enhancement after gadolinium administration in the same distribution during both episodes. This case highlights the possibility that the COVID-19 mRNA vaccine may trigger recurrent acute myocarditis in children and adolescents who have had a previous episode of acute myocarditis.</p>
<p>The FDA has recently approved this vaccine in children 12&nbsp;years and older<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/#bib2">2</a> and recommends that clinicians be aware of the potential for myocarditis to occur following COVID-19 mRNA vaccination'</p>
<p>&nbsp;</p>
<p>Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/</p>
